Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633646 | PMC |
| http://dx.doi.org/10.1007/s10840-017-0277-z | DOI Listing |
Publication Analysis
Top Keywords
2017 hrs/ehra/ecas/aphrs/solaece
4
hrs/ehra/ecas/aphrs/solaece expert
4
expert consensus
4
consensus statement
4
statement catheter
4
catheter surgical
4
surgical ablation
4
ablation atrial
4
atrial fibrillation
4
fibrillation executive
4
Similar Publications
Uninterrupted anticoagulation with non-vitamin K antagonist oral anticoagulants in atrial fibrillation catheter ablation: Lessons learned from randomized trials.
Clin Cardiol
January 2019
Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Catheter ablation has been established as a rhythm control strategy in selected patients with atrial fibrillation (AF) who have failed or wish to avoid anti-arrhythmic drugs. Uninterrupted oral anticoagulation with vitamin K antagonists (VKAs) peri-ablation is associated with a lower risk of thromboembolic and bleeding complications as compared to interrupted oral anticoagulation and bridging heparin. However, a substantial portion of patients with AF are treated with non-vitamin K antagonist oral anticoagulants (NOACs).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!